1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Anders Perner: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial IVIG (Privigen), Saline 0.9% - Necrotizing Soft Tissue Infection, Necrotizing Fasciitis | Phase 2 | Completed | Anders Perner | 100 | 2014-04-01 | 2016-09-30 |
| Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis Ilomedin and Integrilin, low molecular weight heparin. - Pneumonia | Phase 2 | Terminated | Thrombologic ApS | 5 | 2012-06-01 | 2016-04-22 |
Fasciitis, Necrotizing (1) · Fournier Gangrene (1) · Gas Gangrene (1) · Pneumonia (1)
Eptifibatide (1) · Heparin, Low-Molecular-Weight (1) · Immunoglobulin G (1) · Immunoglobulins, Intravenous (1) · Sodium Chloride (1)
Denmark (2) · Finland (1)